Archive: 10/03/2018

Anti-cholesterol drug Praluent cuts death risk

The anti-cholesterol drug Praluent (alirocumab), made by France's Sanofi Pharmaceuticals, is linked to a 15 percent lower risk of major cardiovascular events like heart attack and stroke, a study said Saturday.

Mar 10, 2018
popularity86 comments 0